Aroa Biosurgery

Aroa Biosurgery Limited is a regenerative medicine company based in Auckland, New Zealand, that specializes in developing, manufacturing, and distributing medical devices for wound and soft tissue repair. Founded in 2008, Aroa utilizes its proprietary extracellular matrix (ECM) technology, derived from ovine forestomach, to create products designed to enhance healing in complex wounds and facilitate soft tissue reconstruction. Among its key offerings are Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds, Myriad for soft tissue repair, and Reinforced Bioscaffolds for surgical ventral hernia repair. Aroa's commitment is to improve healing outcomes for patients and healthcare providers, ensuring that its high-quality products are accessible and affordable. The company aims to change the standard of care by delivering innovative solutions that harness the body's natural healing capabilities.